Current knowledge has shed light on the importance of KRAS in cancer metabolism, which is mainly achieved when mutated KRAS enhances the transport of glucose intermediates into different pathways, such as the pentose phosphate pathway and the hexosamine biosynthesis pathway [44]. Here, KRAS is linked to cancer.